Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,097 public trials 1,370 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

NCT02973997

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +38 more
Locations
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT01767675

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Baptist Health South Florida Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer

NCT01723202

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +15 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +45 more
Locations
  • Rutgers, The State University of New Jersey New Brunswick, New Jersey, United States
  • New York University Clinical Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions